Please provide your email address to receive an email when new articles are posted on . Microbial diversity was more prevalent in patients with cured vs. treatment-resistant nontuberculosis ...

A team of scientists has developed a novel antibiotic named COE-PNH2 that is capable of combating hard-to-treat mycobacterial lung infections. Such infections, which are notorious for resisting ...

In a recent article published in Emerging Infectious Diseases journal, researchers performed a retrospective cross-sectional study in Ontario, Canada, to determine the prevalence of nontuberculous ...

In a classic example of scientific problem solving, scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI) and colleagues have published a paper introducing a promising new ...

AN2 Therapeutics Inc.’s decision to pause enrollment in the phase III portion of its phase II/III testing epetraborole in treatment-refractory Mycobacterium avium complex lung disease, citing ...

Q I suffered extensive fatigue that I had attributed to a COVID-19 infection. Then a lung culture found something called mycobacterium avium complex. Would you kindly consider discussing this? I ...

Researchers in the U.S. and U.K. have developed what they say is a more accurate way to scan for tuberculosis (TB) using positron emission tomography (PET) to detect the causative Mycobacterium ...

Rather than battle bacterial infection or reduce sticky buildup in the lungs, these alveolar macrophages (pink) taken from the lungs of a sick child wander aimlessly, the result of a newly discovered ...